SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • October 16th, 2017 • Asterias Biotherapeutics, Inc. • Biological products, (no disgnostic substances) • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of October 16, 2017, between Asterias Biotherapeutics, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
Steven Urbach Chief Executive Officer Chardan Capital Markets, LLC 17 State Street Suite 1600 New York, NY 10004 Tel: 646 465 9003 Fax: 646 465 9091Asterias Biotherapeutics, Inc. • October 16th, 2017 • Biological products, (no disgnostic substances) • New York
